TY  - CONF

T1  - An open-label phase IIa trial assessing the pharmacokinetics, safety and efficacy of dupilumab in a paediatric population with moderate-to-severe atopic dermatitis

JO  - BRITISH JOURNAL OF DERMATOLOGY

PY  - 2017/07/01

AU  - Cork MJ

AU  - Thaci D

AU  - Davis JD

AU  - Zhang Q

AU  - Akinlade B

AU  - Graham NMH

AU  - Pirozzi G

AU  - Bansal A

ED  - 

VL  - 177

SP  - 155

EP  - 155

Y2  - 2024/10/23

ER  -